Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

91.81 -2.00 (-2.13%)
Streaming Delayed Price Updated: 12:44 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
70 71 Next >
News headline image
6 Analysts Have This to Say About BioNTech ↗
 
Via Benzinga
News headline image
Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today? ↗
Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) /  
Via Benzinga
Topics Intellectual Property
News headline image
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology ↗
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to... 
Via Benzinga
Topics Intellectual Property Lawsuit
News headline image
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023 ↗
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode. 
Via InvestorPlace
News headline image
Analyst Ratings for BioNTech ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 6, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
News headline image
Is BioNTech Stock a Buy Now? ↗
Or is it too late to get in on the company after its coronavirus-related success? 
Via The Motley Fool
News headline image
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
News headline image
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal ↗
Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million... 
Via Talk Markets
News headline image
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review ↗
The major indexes ended long win streaks. Datadog led earnings winners. 
Via Investor's Business Daily
News headline image
7 Underappreciated Biotech Stocks to Pick Up on the Cheap ↗
With questions rising about the economy, investors may consider undervalued biotech stocks for their relative insulation factor. 
Via InvestorPlace
Topics Economy
News headline image
Mohamed El-Erian On Yield And Oil Price Drop: Economic Boon Or Major Downturn Ahead? ↗
 
Via Benzinga
News headline image
BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript ↗
BNTX earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday ↗
Eli Lilly jumped, while energy plays were big winners and losers. 
Via Investor's Business Daily
Topics Stocks
News headline image
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside. ↗
The company was expected to report a third-quarter loss and plummeting sales. 
Via Investor's Business Daily
News headline image
Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades ↗
BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago. 
Via Benzinga
News headline image
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields ↗
The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space. 
Via Benzinga
Topics Economy
News headline image
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
News headline image
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares ↗
The company issued below-consensus sales views for 2023 and 2024. 
Via Investor's Business Daily
News headline image
3 No-Brainer Stocks to Buy for Under $100 Right Now ↗
A couple of these stocks might not be available for under $100 for too much longer. 
Via The Motley Fool
News headline image
7 Undervalued Stocks That Analysts Love Right Now ↗
With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal. 
Via InvestorPlace
News headline image
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
From BioNTech SE
Via GlobeNewswire
News headline image
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
From BioNTech SE
Via GlobeNewswire
Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
From BioNTech SE
Via GlobeNewswire
News headline image
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche? ↗
The venerable pharmaceutical companies' shares have slumped this year. 
Via The Motley Fool
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END 
Via FinancialNewsMedia
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
70 71 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.